RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Fulcrum Therapeutics Revenue 2024

Fulcrum Therapeutics Revenue

1.96 M USD

Fulcrum Therapeutics Dividend yield

Ticker

FULC

ISIN

US3596161097

In 2024, Fulcrum Therapeutics's sales reached 1.96 M USD, a -30.3% difference from the 2.81 M USD sales recorded in the previous year.

The Fulcrum Therapeutics Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2029e334.39-
2028e263.3-
2027e190.72-
2026e66.19-
2025e13.6-
2024e1.96-
20232.81-
20226.34-
202119.16-
20208.82-
2019--
2018--
2017--

Fulcrum Therapeutics Aktienanalyse

What does Fulcrum Therapeutics do?

Fulcrum Therapeutics Inc is a biotech company based in Cambridge, Massachusetts, that focuses on developing drugs for treating rare diseases. It was founded in 2015 and has achieved significant milestones since then. The business model of Fulcrum Therapeutics involves utilizing advanced technologies and scientific knowledge to develop new therapies for rare diseases. The company collaborates closely with experts in the field to make groundbreaking discoveries and develop drugs that can improve patients' lives. Fulcrum Therapeutics specializes in three main areas: neuromuscular diseases, rare genetic diseases, and cancer. The company aims to understand the underlying causes of these diseases and develop targeted therapies that meet the specific needs of patients. In terms of neuromuscular diseases, Fulcrum Therapeutics has developed a promising technology called the Product Platform, which aims to better understand the genetic cause of muscle diseases. By using artificial intelligence and large datasets, this technology can help develop new therapies specifically tailored to the needs of patients with muscle diseases. For rare genetic diseases, Fulcrum Therapeutics is working on developing therapies that target the underlying genetic defects. An example is Huntington's disease, a genetic disorder that affects the nervous system and leads to progressive motor impairments and dementia. Fulcrum is developing drugs that specifically target the genetic defect causing Huntington's disease, aiming to enable more effective treatment. In the field of cancer, Fulcrum Therapeutics is working on new immunotherapies that utilize the body's immune system to fight the spread of cancer cells. The company primarily utilizes a T-cell technology for this purpose. To achieve these goals, the company collaborates closely with academic institutions, medical experts, and other industry partners. It has quickly built an experienced and interdisciplinary team of scientists, developers, and executives focused on developing innovative therapies for treating rare diseases. In conclusion, Fulcrum Therapeutics Inc is a company with a unique and promising business model. The company is dedicated to developing new therapies for patients with rare diseases by utilizing innovative technologies and scientific knowledge. If successful, Fulcrum Therapeutics' research has the potential to improve the lives of millions of people worldwide. Fulcrum Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Fulcrum Therapeutics's Sales Figures

The sales figures of Fulcrum Therapeutics originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Fulcrum Therapeutics’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Fulcrum Therapeutics's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Fulcrum Therapeutics’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Fulcrum Therapeutics Stock

How much revenue did Fulcrum Therapeutics generate this year?

Fulcrum Therapeutics has achieved a revenue of 1.96 M USD this year.

How much was the turnover of the company Fulcrum Therapeutics compared to the previous year?

The revenue of Fulcrum Therapeutics has increased by -30.3% decreased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Fulcrum Therapeutics?

The revenue of Fulcrum Therapeutics is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Fulcrum Therapeutics measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Fulcrum Therapeutics so important for investors?

The revenue of Fulcrum Therapeutics is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Fulcrum Therapeutics pay?

Over the past 12 months, Fulcrum Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Fulcrum Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Fulcrum Therapeutics?

The current dividend yield of Fulcrum Therapeutics is .

When does Fulcrum Therapeutics pay dividends?

Fulcrum Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Fulcrum Therapeutics?

Fulcrum Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Fulcrum Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Fulcrum Therapeutics located?

Fulcrum Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Fulcrum Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Fulcrum Therapeutics from 5/21/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/21/2024.

When did Fulcrum Therapeutics pay the last dividend?

The last dividend was paid out on 5/21/2024.

What was the dividend of Fulcrum Therapeutics in the year 2023?

In the year 2023, Fulcrum Therapeutics distributed 0 USD as dividends.

In which currency does Fulcrum Therapeutics pay out the dividend?

The dividends of Fulcrum Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Fulcrum Therapeutics

Our stock analysis for Fulcrum Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fulcrum Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.